High precision, quantitative, digital image analysis services benefit the pharmaceutical industry in numerous ways, from pre-clinical and clinical research to drug discovery and detection of defects in pills. Clinical research organizations (CROs) provide image analysis services applicable to studies involving drug efficacy/toxicity, biomarker analysis in tissues, target quantification in diseased versus non-diseased tissues, and more. With regard to a more specialized field, histology, service providers leverage various image analysis techniques to deliver accurate and detailed quantification of the nuclear membrane and cytoplasmic markers on a cell-by-cell basis within tissue sections. These services can help understand the mechanism of new oncology immunotherapies, determine the effectiveness of emerging treatments, perform tissue microarray analysis, and more.
Image analysis service companies with deep expertise in highly complex imaging provide end-to-end cell culture assays as well as three-dimensional characterization of tissues for solving sophisticated research problems and evaluating complicated phenotypes. These companies also help transform 3D tissues into valuable 3D insights and enable the development of customized 3D cell culture models. Furthermore, CROs supporting international trials with advanced image acquisition and analysis technologies offer services that drive the translation of novel imaging technologies and post-processing modalities from development to application in clinical trials.
As a variety of image analysis services can help address diverse aspects within the pharmaceutical industry, organizations must resort to the service that best fits their requirements. In the same vein, our distinguished panel comprising key decision makers and experts along with Pharma Tech Outlook’s editorial board has shortlisted some of the most promising image analysis consulting/services companies.
We present to you Pharma Tech Outlook’s “Top 10 Image Analysis Consulting/ Services Companies - 2019.”